Placeholder

Middle markets

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 1560. Category: .

Product Description

Blockbuster drugs are sexy, exciting, and they generate widespread attention.
They monopolize the advertising budgets of their marketers and developers, who work to ensure that their attributes are seen by millions of consumers via television and in magazines. As a result of the Herculean promotional efforts of marketing powerhouses such as Pfizer, Merck & Co., AstraZeneca, and GlaxoSmithKline, there is a new yardstick by which blockbusters are measured — those that generate sales between $700 million and $4 billion. About 100 brands fall…

Sidebar:
High Hurdles Big Returns
The Pfizer Market Model

Experts on this topic
Chris Bogan. President and CEO, Best Practices LLC, Chapel Hill, N.C.; Best Practices offers experience in the application of best-practice benchmarking strategies
Mariann Caprino. Director of Media Relations, Pfizer Inc., New York; Pfizer is a global pharmaceutical company
Friedman, Billings, Ramsey & Co. Arlington, Va.; FRB is an institutional brokerage, research, and investment banking company
Daniel Glassman. Chairman, CEO, and President, Bradley Pharmaceuticals Inc., Fairfield, N.J.; Bradley markets prescription and ethically promoted nonprescription drugs
James Green. Senior Director, Public Affairs, King Pharmaceuticals Inc., Bristol, Tenn.; King is a vertically integrated pharmaceutical company that manufactures, and markets primarily branded prescription pharmaceutical products
Jefferson J. Gregory. President, King Pharmaceuticals Inc., Bristol, Tenn.; King is a vertically integrated pharmaceutical company that manufactures and markets primarily branded prescription pharmaceutical products
John M. Gregory. Chairman and CEO, King Pharmaceuticals Inc., Bristol, Tenn.; King is a vertically integrated pharmaceutical company that manufactures and markets primarily branded prescription pharmaceutical products
Joe Krivulka. President, Reliant Pharmaceuticals LLC, Liberty Corner, N.J.; Reliant is an emerging specialty pharmaceutical company
Rich Levy. President and Chief Operating Officer, Adair-Greene Inc., Atlanta; Adair-Greene is a full-service marketing communications agency
Lynn O’Connor Vos. CEO, Grey Healthcare Group, New York; Grey is a global healthcare advertising agency
David Winigrad. President, The Hal Lewis Group, Philadelphia; Hal Lewis is an independent healthcare advertising agency

 

FEEDBACK